BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
275 hedge funds and large institutions have $3.41B invested in bluebird bio in 2020 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 100 increasing their positions, 84 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 278 → 275 (-3)
13% less capital invested
Capital invested by funds: $3.94B → $3.41B (-$526M)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Holders
275
Holding in Top 10
1
Calls
$55.7M
Puts
$54.3M
Top Buyers
| 1 | +$18.4M | |
| 2 | +$14.2M | |
| 3 | +$12.5M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.1M |
| 5 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
+$11.9M |
Top Sellers
| 1 | -$42M | |
| 2 | -$25.7M | |
| 3 | -$22.9M | |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$19.8M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$16.7M |